DAHLIA CARR, MD
Rheumatology Physician · BEVERLY HILLS, CA
Individual Active NPI 1356368930
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 431 | 45,841 | $1,621,426 | $951,737 | $763,176 |
| 2023 | 403 | 44,519 | $1,580,591 | $845,133 | $672,008 |
| 2022 | 403 | 25,836 | $1,131,956 | $581,328 | $461,656 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | 21,120 | $26 | $21 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 18,480 | $11 | $9 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 1,260 | $0 | $0 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 883 | $139 | $105 |
| 96372 | Injection of drug or substance under skin or into muscle | 373 | $16 | $13 |
| 36415 | Insertion of needle into vein for collection of blood sample | 265 | $9 | $9 |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 210 | $82 | $63 |
| 80053 | Blood test, comprehensive group of blood chemicals | 205 | $10 | $10 |
| 84550 | Uric acid level, blood | 204 | $4 | $4 |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | 204 | $4 | $4 |
| 82248 | Bilirubin level, direct | 202 | $5 | $5 |
| 84100 | Phosphate level | 202 | $5 | $5 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Rheumatology Physician | 207RR0500X | ✓ | A80951 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Rheumatology Physician providers in California
- NPI 1023645686
- NPI 1174692131
- NPI 1689864332
- NPI 1124160163
- NPI 1609221506
- NPI 1831452101
- NPI 1215934971
- NPI 1699793570
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.